These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9667661

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
    Cooper BC, Ritchie JM, Broghammer CL, Coffin J, Sorosky JI, Buller RE, Hendrix MJ, Sood AK.
    Clin Cancer Res; 2002 Oct; 8(10):3193-7. PubMed ID: 12374688
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
    Candido Dos Reis F, Moreira de Andrade J, Bighetti S.
    Gynecol Obstet Invest; 2002 Oct; 54(3):132-6. PubMed ID: 12571433
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic value of serum VEGF in women with ovarian tumors.
    Oehler MK, Caffier H.
    Anticancer Res; 1999 Oct; 19(4A):2519-22. PubMed ID: 10470186
    [Abstract] [Full Text] [Related]

  • 7. Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome.
    Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Ciampi B, Prontera C, Genazzani AR.
    Anticancer Res; 1999 Oct; 19(2B):1401-5. PubMed ID: 10365113
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Study on serum vascular endothelial growth factor level in ovarian malignant tumors].
    Li L, Wang LM, Zhang W, Zhang JQ, Song HL, Yao DS, Tang Y, Chen XQ, Yang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):72-6. PubMed ID: 12783691
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of serum vascular endothelial growth levels between patients with and without ovarian malignancies.
    Dehaven K, Taylor DD, Gercel-Taylor C.
    Int J Gynecol Cancer; 2002 Feb; 12(6):715-9. PubMed ID: 12445248
    [Abstract] [Full Text] [Related]

  • 19. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
    Zhao J, Hu J, Cai J.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769
    [Abstract] [Full Text] [Related]

  • 20. Do preoperative serum vascular endothelial growth factor and migration-inhibitory factor predict the nature of the adnexal masses? A prospective-controlled trial.
    Yildirim N, Dikmen Y, Terek MC, Akman L, Gunel NS, Aktan C, Zekioglu O, Gunduz C.
    J Obstet Gynaecol; 2016 May; 36(4):533-7. PubMed ID: 26758243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.